Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The president of Emerging World Pharma, Brandon Keks has confirmed that the company has approved an ongoing investment allocation into European Global Pharma. The first allotment of funding has been set aside as the company completed its due diligence.
Subscribe to our email newsletter
Emerging World Pharma is an investor in generic based pharmaceutical companies manufacturing within developing nations.
Emerging World Pharma said that the investment will be used to fund generic drug manufacturing facilities in Estonia and eventually expand into Eastern European countries.
Reportedly, Emerging World Pharma’s investment into African Global Pharma Sunyani, Ghana’s generic pharmaceutical facility, is on schedule to be operational by the end of May 2010.
Brandon Keks, president of Emerging World Pharma, said: “We believe the investment into European Global Pharma via Estonia will provide a corridor for continued growth and development of generic pharmaceutical manufacturing into Eastern Europe and surrounding Baltic regions.”